Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$233.08 - $265.59 $120 Million - $137 Million
-515,700 Reduced 61.27%
326,000 $80.9 Million
Q2 2023

Aug 14, 2023

SELL
$224.99 - $256.14 $14.5 Million - $16.5 Million
-64,300 Reduced 7.1%
841,700 $202 Million
Q1 2023

May 15, 2023

BUY
$239.75 - $277.0 $217 Million - $251 Million
906,000 New
906,000 $228 Million
Q1 2022

May 16, 2022

SELL
$257.27 - $315.76 $71.3 Million - $87.5 Million
-277,035 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$292.08 - $329.01 $455 Million - $512 Million
-1,557,386 Reduced 84.9%
277,035 $91.1 Million
Q3 2021

Nov 15, 2021

SELL
$272.21 - $332.43 $138 Million - $169 Million
-507,000 Reduced 21.65%
1,834,421 $558 Million
Q2 2021

Aug 16, 2021

SELL
$225.08 - $271.69 $70.6 Million - $85.3 Million
-313,785 Reduced 11.82%
2,341,421 $628 Million
Q1 2021

May 17, 2021

BUY
$212.38 - $245.9 $15.5 Million - $17.9 Million
72,860 Added 2.82%
2,655,206 $598 Million
Q4 2020

Feb 16, 2021

BUY
$212.5 - $245.46 $257 Million - $297 Million
1,210,565 Added 88.25%
2,582,346 $574 Million
Q3 2020

Nov 16, 2020

SELL
$177.16 - $215.33 $325 Million - $394 Million
-1,831,775 Reduced 57.18%
1,371,781 $295 Million
Q2 2020

Aug 14, 2020

SELL
$128.7 - $176.83 $87.2 Million - $120 Million
-677,810 Reduced 17.46%
3,203,556 $566 Million
Q1 2020

May 15, 2020

BUY
$121.39 - $169.05 $471 Million - $656 Million
3,881,366 New
3,881,366 $537 Million
Q2 2019

Aug 14, 2019

SELL
$124.88 - $143.73 $150 Million - $172 Million
-1,200,000 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$97.62 - $132.29 $53.7 Million - $72.8 Million
550,000 Added 84.62%
1,200,000 $158 Million
Q4 2018

Feb 14, 2019

BUY
$94.85 - $109.54 $61.7 Million - $71.2 Million
650,000 New
650,000 $67 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $171B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track D1 Capital Partners L.P. Portfolio

Follow D1 Capital Partners L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D1 Capital Partners L.P., based on Form 13F filings with the SEC.

News

Stay updated on D1 Capital Partners L.P. with notifications on news.